Yona Kalechman

A new immunomodulating compound (AS-101) with potential therapeutic application

Benjamin Sredni, Rachel R Caspi, A. Klein et al. · Nature · 1987 · 185 citations

New Immunomodulating Compound, Immunology, Autoimmunity +5

Anti-IL-10 Therapeutic Strategy Using the Immunomodulator AS101 in Protecting Mice from Sepsis-Induced Death: Dependence on Timing of Immunomodulating Intervention

Yona Kalechman, Uzi Gafter, Rivka Gal et al. · The Journal of Immunology · 2002 · 135 citations · Full text

Il-10 Expression, Immune Regulation, Immunology +20

Induction of a subpopulation of suppressor cells by a single blood transfusion

Uzi Gafter, Yona Kalechman, Benjamin Sredni · Kidney International · 1992 · 102 citations · Full text

Transplantation, Transfusion Medicine, Immunology +9

Ammonium Trichloro(dioxoethylene-<b><i>o,o</i></b>′)tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop

Benjamin Sredni, Merav Weil, Gennadi Khomenok et al. · Cancer Research · 2004 · 96 citations

Predominance of TH1 Response in Tumor-Bearing Mice and Cancer Patients Treated With AS 101

Benjamin Sredni, Thomas Tichler, Adi Shani et al. · JNCI Journal of the National Cancer Institute · 1996 · 91 citations